SI9420053A - New bis-naphthalimide compounds for treatment of cancer - Google Patents

New bis-naphthalimide compounds for treatment of cancer Download PDF

Info

Publication number
SI9420053A
SI9420053A SI9420053A SI9420053A SI9420053A SI 9420053 A SI9420053 A SI 9420053A SI 9420053 A SI9420053 A SI 9420053A SI 9420053 A SI9420053 A SI 9420053A SI 9420053 A SI9420053 A SI 9420053A
Authority
SI
Slovenia
Prior art keywords
bis
formula
compound
ethyl
naphthalimido
Prior art date
Application number
SI9420053A
Other languages
English (en)
Slovenian (sl)
Inventor
Gerhard Keilhauer
Cynthia Romerdahl
Brana Miguel Fernandez
Xiao-Dong Qian
Peter Bousquet
Berlanga Jose Maria Castellano
Moset Marina Moran
De Vega Maria Jesus Perez
Original Assignee
Basf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Ag filed Critical Basf Ag
Publication of SI9420053A publication Critical patent/SI9420053A/sl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04—Ortho- or peri-condensed ring systems
    • C07D221/06—Ring systems of three rings
    • C07D221/14—Aza-phenalenes, e.g. 1,8-naphthalimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Lubricants (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
SI9420053A 1993-08-18 1994-08-08 New bis-naphthalimide compounds for treatment of cancer SI9420053A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10894993A 1993-08-18 1993-08-18

Publications (1)

Publication Number Publication Date
SI9420053A true SI9420053A (en) 1996-08-31

Family

ID=22324990

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9420053A SI9420053A (en) 1993-08-18 1994-08-08 New bis-naphthalimide compounds for treatment of cancer

Country Status (28)

Country Link
US (3) US5616589A (cs)
EP (1) EP0714387B1 (cs)
JP (1) JPH09501662A (cs)
KR (1) KR960703863A (cs)
CN (1) CN1039414C (cs)
AT (1) ATE166647T1 (cs)
AU (1) AU677696B2 (cs)
BR (2) BR9407257A (cs)
CA (1) CA2169059A1 (cs)
CZ (1) CZ34296A3 (cs)
DE (1) DE69410614T2 (cs)
DK (1) DK0714387T3 (cs)
ES (1) ES2116612T3 (cs)
FI (1) FI960658A0 (cs)
HR (1) HRP940458B1 (cs)
HU (1) HU219232B (cs)
IL (1) IL110460A (cs)
NO (1) NO305554B1 (cs)
NZ (1) NZ271374A (cs)
PH (1) PH31395A (cs)
PL (1) PL313078A1 (cs)
RU (1) RU2138484C1 (cs)
SG (1) SG64906A1 (cs)
SI (1) SI9420053A (cs)
TW (1) TW408112B (cs)
UA (1) UA42733C2 (cs)
WO (1) WO1995005365A1 (cs)
ZA (1) ZA946196B (cs)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5703089A (en) * 1994-04-28 1997-12-30 Knoll Aktiengesellschaft Dihydrodibenzisoquinolinediones
IL129475A0 (en) * 1996-10-21 2000-02-29 Allelix Biopharma Neurotrophin antagonist compositions
WO2000055166A1 (en) 1999-03-16 2000-09-21 Regents Of The University Of California Glycosylated polyamines
US6531454B1 (en) 1999-03-16 2003-03-11 The Regents Of The University Of California Glycosylated polyamines and methods of use therefor
US6492380B1 (en) * 1999-05-17 2002-12-10 Queen's University At Kingston Method of inhibiting neurotrophin-receptor binding
US6468990B1 (en) * 1999-05-17 2002-10-22 Queen's University At Kingston Method of inhibiting binding of nerve growth factor to p75 NTR receptor
CA2402446C (en) 2000-03-07 2011-05-17 Wieslaw M. Cholody 1,8-naphthalimide imidazo[4,5,1-de]acridones with anti-tumor activity
DE602004032400D1 (de) 2003-11-05 2011-06-01 Photobiomed Corp Verbindungsgewebe und Vernetzungsproteine mit Naphthalimid-Verbindungen
CA2555718A1 (en) * 2004-05-05 2005-11-10 Unibioscreen S.A. Naphthalimide derivatives for the treatment of cancer
US7947839B2 (en) 2004-12-01 2011-05-24 Genentech, Inc. Heterocyclic-substituted bis-1,8 naphthalimide compounds, antibody drug conjugates, and methods of use
US20070134243A1 (en) * 2004-12-01 2007-06-14 Gazzard Lewis J Antibody drug conjugates and methods
WO2006060533A2 (en) 2004-12-01 2006-06-08 Genentech, Inc. Conjugates of 1, 8-bis-naphthalimides with an antibody
KR20080058403A (ko) 2005-09-15 2008-06-25 페인셉터 파마 코포레이션 뉴로트로핀 매개 활성 조절 방법
WO2009089537A2 (en) 2008-01-11 2009-07-16 Northwestern University Anti-cancer compounds

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3535496A1 (de) * 1985-10-04 1987-04-16 Bayer Ag Verfahren zur fluoreszenzloeschung und neue kationische naphthalin-peri-dicarbonsaeureimid-derivate
DE3707651A1 (de) * 1987-03-10 1988-09-22 Knoll Ag Bis-naphthalimide, ihre herstellung und verwendung
US5086052A (en) * 1987-07-17 1992-02-04 Abbott Laboratories Substituted 1,4,5,6-tetrahydro-2H-pyridazin-3-one and -3-thione compounds having lipoxygenase inhibitory activity
US5086059A (en) * 1990-06-07 1992-02-04 Du Pont Merck Pharmaceutical Company Bis-naphthalimides as anticancer agents
US5206249A (en) * 1991-03-27 1993-04-27 Du Pont Merck Pharmaceutical Company Bis-naphthalimides containing amino-acid derived linkers as anticancer agents
ES2088661T3 (es) * 1991-12-11 1996-08-16 Du Pont Merck Pharma Bis-naftalimidas fuertemente solubles en agua utiles como agentes anti-cancerigenos.
DE4232739A1 (de) * 1992-09-30 1994-03-31 Knoll Ag Neue asymmetrisch substituierte bis-Naphthalimide

Also Published As

Publication number Publication date
US5789418A (en) 1998-08-04
SG64906A1 (en) 1999-05-25
CN1039414C (zh) 1998-08-05
EP0714387A1 (en) 1996-06-05
AU7498494A (en) 1995-03-14
KR960703863A (ko) 1996-08-31
NO960632L (no) 1996-02-16
EP0714387B1 (en) 1998-05-27
NO960632D0 (no) 1996-02-16
RU2138484C1 (ru) 1999-09-27
PL313078A1 (en) 1996-05-27
BR1100143A (pt) 2000-03-14
HU9600360D0 (en) 1996-04-29
IL110460A (en) 2001-01-11
BR9407257A (pt) 1996-09-24
UA42733C2 (uk) 2001-11-15
NZ271374A (en) 1997-05-26
ATE166647T1 (de) 1998-06-15
PH31395A (en) 1998-10-29
DK0714387T3 (da) 1998-10-12
DE69410614D1 (de) 1998-07-02
DE69410614T2 (de) 1998-09-24
NO305554B1 (no) 1999-06-21
JPH09501662A (ja) 1997-02-18
FI960658A (fi) 1996-02-14
CA2169059A1 (en) 1995-02-23
CN1132506A (zh) 1996-10-02
WO1995005365A1 (en) 1995-02-23
ES2116612T3 (es) 1998-07-16
FI960658A0 (fi) 1996-02-14
HUT73529A (en) 1996-08-28
CZ34296A3 (en) 1996-08-14
HRP940458A2 (en) 1997-06-30
IL110460A0 (en) 1994-10-21
HU219232B (en) 2001-03-28
US5981753A (en) 1999-11-09
AU677696B2 (en) 1997-05-01
US5616589A (en) 1997-04-01
HRP940458B1 (en) 2000-02-29
TW408112B (en) 2000-10-11
ZA946196B (en) 1996-02-19

Similar Documents

Publication Publication Date Title
SI9420053A (en) New bis-naphthalimide compounds for treatment of cancer
JP3447292B2 (ja) イミダゾピリジン及び胃腸の疾病の治療のためのその使用
KR100640672B1 (ko) 파르네실 단백질 트랜스퍼라제의 억제에 유용한 벤즈피리도 사이클로헵탄 화합물 및 이를 포함하는 약제학적 조성물
JPH08511802A (ja) ビス−イミド抗腫瘍剤のための多環式および複素環式発色団
US5703089A (en) Dihydrodibenzisoquinolinediones
DE69020368T2 (de) 3-Phenyl-5,6-dihydro(C)-acridin-7-carboxylsäure und verwandte Verbindungen als chemotherapeutische Wirkstoffe gegen Krebs.
DE69119323T2 (de) Fluoräthylcamptothecinderivate
TW397826B (en) High purity 6,9-bis[(2-aminoethyl)amino]benzno[G]-isoquinoline-5,10-dione dimaleate and method of synthesis
US5747502A (en) Process for preparing benzo c!phenanthridinium derivatives, novel compounds prepared by said process, and antitumor agents
AU2003248910B2 (en) Naphthalimide synthesis including amonafide synthesis and pharmaceutical preparations thereof
TW307764B (cs)
EP0618901A1 (en) BIS-NAPHTALIMIDES HIGHLY SOLUBLE IN WATER USEFUL AS ANTI-CANCER AGENTS.
JPH05508639A (ja) １，２―ジヒドロ―３ｈ―ジベンズイソキノリン―１，３―ジオン抗ガン剤
EP0487930B1 (en) Benzo[C]phenanthridinium derivatives
AU666847B2 (en) Bis-naphthalimides containing amino-acid derived linkers as anticancer agents
WO1991005770A1 (en) Potential anticancer agents derived from acridine
CA2227513C (fr) Nouveaux derives d'ellipticine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
ITMI971850A1 (it) Derivati di pirazolo-acridine aventi attivita' antitumorale
ITMI971851A1 (it) Derivati di ammino-acridine carbossiammidi aventi attivita' antitumorale
JPH06211787A (ja) Ｎ−フェネチルアゼピン誘導体およびその用途